Bioxytran, Inc. filed its 10-K on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, B F Borgers CPA PC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1046 USD | +3.46% | -4.56% | -30.27% |
Apr. 19 | Bioxytran, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 19 | Bioxytran, Inc. Announces Board Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-30.27% | 17.68M | |
+8.85% | 105B | |
-0.68% | 104B | |
+5.79% | 22.94B | |
-12.62% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-9.21% | 16.96B | |
+7.79% | 14.16B | |
+37.67% | 12.63B |
- Stock Market
- Equities
- BIXT Stock
- News Bioxytran, Inc.
- Bioxytran, Inc. Auditor Raises 'Going Concern' Doubt